WIN consortium, organiser of the WIN symposia series, is a network of 37 academic and industry members that have come together from all parts of the world to address the challenge of increasing the efficacy of cancer diagnostics and therapeutics by understanding the genetics and biology of each individual's tumor and accounting for genetic differences across diverse populations. We warmly invite you to attend the 12th Annual WIN Symposium that will take place on 29-30 October 2022 in Barcelona, Spain. We are looking forward to finally meeting you again in person at the WIN 2022 Symposium! Everything will be done to ensure your safety during this period of pandemic. As always, WIN 2022 Symposium will gather renowned experts in personalised cancer medicine from all over the world, and will explore innovative ways to bolster precision oncology by integrating transcriptomics to the current armamentarium of genomics. Your attendance will also be an invaluable opportunity to engage and network with all the different parties attending this year's symposium, from academia, industry, non-profit, and patient advocacy. The 2022 Symposium will be dedicated to sharing the latest precision oncology developments and research from across the globe: . 30 Precision Oncology leaders from academia, industry, and research organisations . Over 70 thought-provoking abstracts from like-minded professionals . Showcase of the latest research work and findings Time: 8:00 am to 6:00 pm